Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000251573 | SCV000310559 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV001094492 | SCV000411576 | likely benign | Congenital nephrotic syndrome | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Genome Diagnostics Laboratory, |
RCV000277714 | SCV000743921 | benign | Finnish congenital nephrotic syndrome | 2015-07-20 | criteria provided, single submitter | clinical testing | |
SIB Swiss Institute of Bioinformatics | RCV000277714 | SCV000803437 | benign | Finnish congenital nephrotic syndrome | 2018-05-31 | criteria provided, single submitter | curation | This variant is interpreted as a Benign - Stand Alone, for Nephrotic syndrome, type 1, in Autosomal Recessive manner. The following ACMG Tag(s) were applied: BA1 => Allele frequency is >5% in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. |
Athena Diagnostics | RCV000712420 | SCV000842912 | benign | not provided | 2017-08-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000712420 | SCV001719671 | benign | not provided | 2025-01-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000277714 | SCV001738131 | benign | Finnish congenital nephrotic syndrome | 2021-06-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000712420 | SCV001860434 | benign | not provided | 2019-10-15 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 31216994, 27884173, 9915943, 21228398, 20981092, 20507940, 11726550, 24742477) |
Genome Diagnostics Laboratory, |
RCV002294138 | SCV002587634 | benign | Atypical hemolytic-uremic syndrome | 2021-10-09 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000712420 | SCV005207021 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV000277714 | SCV000733876 | benign | Finnish congenital nephrotic syndrome | no assertion criteria provided | clinical testing | ||
Natera, |
RCV000277714 | SCV001460542 | benign | Finnish congenital nephrotic syndrome | 2020-09-16 | no assertion criteria provided | clinical testing | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000251573 | SCV001952621 | benign | not specified | no assertion criteria provided | clinical testing |